Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-09-08
Item 5.07
This is a clear disclosure of shareholder vote results from Mesa's annual meeting held on September 8, 2026. The filing presents certified voting outcomes for three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and advisory approval of named executive officer compensation. This is the quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor selection.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-08
Item 5.02
David Noerby Foss Kowalczyk, the Chief Financial and Operating Officer, notified the Company of his intention to resign effective November 30, 2026. This is a clear departure of a named executive officer holding a senior dual role (CFO and COO). The filing explicitly states the departure is not due to disagreement, but the resignation of a C-suite officer responsible for financial and operational oversight is material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-08
Item 8.01
The filing discloses an at-the-market (ATM) offering program under which Aqua Metals may sell shares of common stock. Although the Item 8.01 disclosure focuses on the administrative assignment of the Sales Agreement from Benchmark to StoneX Financial Inc., the underlying ATM arrangement itself is a dilutive equity issuance mechanism that would materially affect shareholders through potential dilution. ATM offerings are typically classified as dilutive issuances under Item 3.02, and this disclosure confirms the active program remains in place.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-08
Item 7.01
Loop Industries announced the appointment of Jeffrey R. Geygan as Chairman of the Board of Directors, with founder and CEO Daniel Solomita retaining his CEO role but relinquishing the Chairman title. This represents a material governance change involving the appointment of a new board leader with significant capital-markets and public-company experience, coupled with a structural separation of the Chairman and CEO roles. The press release emphasizes this as strengthening corporate governance and enabling focused commercial execution.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-09-08
Item 3.01
Aterian received a formal notice from Nasdaq on September 2, 2026, that its common stock failed to maintain the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company has been granted a 180-day compliance period ending March 1, 2027, to regain compliance, with failure to do so potentially resulting in delisting.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-08
Item 5.02
Joshua Feldman, Chief Financial Officer and principal financial officer, was terminated on September 4, 2026, pursuant to a Transition and Separation Agreement, with severance benefits triggered.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-08
Item 2.02
MIND Technology issued a press release on September 8, 2026 announcing financial results for the fiscal 2027 second quarter ended July 31, 2026, disclosing revenues of $5.6 million, an operating loss of $1.8 million, and a net loss of $1.7 million ($0.19 per share).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-08
Item 5.02
David Garcia Rios was appointed as a Class II director of the Board, effective September 2, 2026, exercising SFF's contractual board designation right under the January 2026 Investors' Rights Agreement. Garcia Rios brings expertise in digital assets and corporate governance to the cryptocurrency-focused company.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-09-08
Item 3.03
The company disclosed a material modification to the rights of security holders through amendments to its Articles of Incorporation or Bylaws, with details incorporated by reference from Item 5.03.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-09-08
Item 8.01
The filing discloses the results of the September 3, 2026 Annual Meeting of Stockholders, specifically that Proposal 4 (seeking stockholder approval for issuance of 1,236,668 shares upon warrant exercise under NASDAQ Rule 5635(d)) failed to receive sufficient votes at the time of the meeting, prompting adjournment to October 2, 2026. This is a material shareholder vote outcome affecting the Company's ability to proceed with a dilutive warrant issuance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-08
Item 7.01
The disclosure centers on execution of a non-binding Letter of Intent with EthosEnergy O&M for operations and maintenance services of the Lufkin power facility, contingent on successful acquisition completion. This is a material operational/strategic milestone—identifying and securing a qualified O&M partner for a 55 MW facility supporting the Company's data center strategy—but does not fit the specific categories of M&A activity (the LOI is non-binding and the acquisition itself remains pending), debt issuance, or other named event types. The operational significance and materiality to investors evaluating the Company's ability to execute its Lufkin project strategy support classification as operational_other rather than a routine disclosure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-08
Item 3.03
This disclosure reports a 1-for-100 reverse share split approved by the board and shareholders on August 20, 2026, reducing outstanding shares from approximately 19.99 million to 0.20 million. While reverse splits modify security holder rights and capital structure, this is a governance/corporate action event that does not fit the specific material event categories (not an M&A, not a delisting risk per se, not a dilutive issuance). The event is material to investors as it affects share count, trading symbol, and CUSIP, but is best classified as a governance matter outside the named taxonomy.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-08
Item 8.01
Lightbridge was selected for the U.S. Department of Energy's Launch Pad INL Program, a material operational and strategic milestone that accelerates the company's commercialization pathway for its advanced nuclear fuel technology. The program enables a two-pronged strategy (SHED facility under DOE authorization and LEFF under NRC licensing) that could accelerate time-to-market by several years, representing one of the most consequential milestones in the company's history.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-08
Item 1.01
Greenwave entered into a Preferred Stock Purchase Agreement on September 7, 2026, for a private placement of 3,750 shares of Series B Convertible Preferred Stock convertible into approximately 715,649 shares of common stock at $5.24 per share, raising approximately $3.75 million. The transaction is exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D, and Item 3.02 explicitly incorporates the transaction as an unregistered sale of equity securities. This is a classic dilutive private placement raising capital through convertible preferred stock.
View raw filing on EDGAR →
8-K
Going Concern
confidence 75%
filed 2026-09-08
The filing explicitly discloses "substantial doubt regarding the Company's ability to continue as a going concern" and states that "Its auditors issued a going concern qualification expressing substantial doubt about the Company's ability to continue as a going concern." This language appears prominently in both the cautionary statements and the "Certain Information Regarding the Company's Financial Condition" section, making going concern the most material event disclosed, despite the Item 7.01 framing around cost reductions.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-08
The filing discloses that Galmed regained compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)) after previously failing to maintain $1.00 per share for 30 consecutive trading days. The Company was notified of non-compliance on January 29, 2026, given a 180-day cure period (extended to 360 days total), and ultimately achieved compliance by September 3, 2026. This is a delisting-risk resolution: the Company faced potential delisting and has now cured the deficiency, bringing it back into full compliance with all applicable listing standards.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-08
Item 1.02
The filing discloses termination of a material merger agreement between Cayson Acquisition Corp and Mango Financial Group Limited that had been in place since July 11, 2025. The termination on September 2, 2026 represents a material change in the Company's M&A status, with ongoing financial obligations (promissory notes with conversion rights) and the SPAC resuming its search for a target business combination. This is a termination of a material definitive agreement under Item 1.02, which is a core M&A event type.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-08
The 6-K discloses the final results of an extraordinary general meeting held on September 8, 2026, where shareholders voted on three proposals: adoption of amended and restated memorandum and articles of association (Proposal One, passed with 99.998% affirmative votes), authorization for directors to implement the amendments (Proposal Two, passed with 99.999% affirmative votes), and authorization to adjourn if needed (Proposal Three, also passed but rendered moot). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the amendments to governance provisions and dispute resolution jurisdiction are material to investors' understanding of the company's governance structure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-08
EX-99.1
This exhibit is a press release announcing unaudited financial results for the fourth quarter and full fiscal year ended June 30, 2026. The document discloses total revenue of US$104.7 million (down 11.4% YoY), net income of US$3.9 million (up 0.8% YoY), and detailed operating metrics. The company also provides forward guidance for Q1 FY2027 revenue of US$20–23 million. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the registrant's financial performance and strategic transition toward AI-generated content.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-08
EX-99.4
This exhibit discloses the completion of a material acquisition: MKDWELL Tech Inc. acquired 100% of Landvision Inc. for US$240 million in stock consideration (30 million shares at US$8.00 per share), completed on August 7, 2026. The pro forma financial statements show the combined entity with Landvision's revenues of US$132.1 million for the six-month period, representing a transformative transaction that materially changes the registrant's asset base, equity structure, and operating profile. This is a classic M&A completion disclosure under Item 1.01 / 2.01 equivalent for a 6-K.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-08
Nova Minerals disclosed the arrival of approximately 500 tons of processing and refining equipment in Alaska as a significant milestone toward establishing its antimony production facility, funded by a $43.4 million Department of War award under the Defense Production Act. This represents material operational progress on a critical minerals project with national security implications and production targeted for 2027, disclosed via Item 7.01 (Regulation FD Disclosure) press release. While the event is clearly operational and strategic in nature, it does not fit neatly into a specific named category (not a contract, partnership, or regulatory milestone per se, but rather project development progress), making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-08
The filing discloses the promotion of Thomas Englese to Chief Commercial Officer of Tonix Pharmaceuticals, effective immediately on September 8, 2026. Englese had previously served as Executive Vice President of Commercial Operations since September 2024 and will now lead the company's commercial organization overseeing sales, marketing, and market access for TONMYA and other marketed products. This is a material executive appointment to a C-suite officer role at a commercial-stage biopharmaceutical company.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-08
EX-99.1
Pulsenmore announced completion of CE European registration for its Pulsenmore FC home ultrasound system for fertility monitoring, marking the company's second product authorized in Europe and first expansion beyond prenatal care into women's health. This is a material regulatory milestone enabling market entry across European markets, but does not fit discrete event categories (not M&A, not a financial result, not an executive change, not a restatement or impairment). The disclosure is clearly operational—a product regulatory approval and market expansion milestone—making operational_other the appropriate classification.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-08
Soluna announced completion of Project Kati 1 (83 MW energized) and conditional Base Load classification from ERCOT for the full 166 MW campus. This represents a material operational milestone—the company delivered on its timeline, increased total operating capacity to 206 MW, and secured favorable grid interconnection status. While not a traditional M&A, earnings release, or governance event, this operational achievement materially advances the company's strategic capacity expansion and grid positioning.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-08
The filing's primary substantive disclosure is the termination of a Management Services Agreement with Ethereum Tower (Item 1.02) and replacement with a new advisory services agreement with American Validator LLC at a simplified 1.50% fee structure. While this involves a material contract change affecting the Company's Ethereum staking operations, it does not fit neatly into the specific financial or operational categories. The termination itself was not penalizing, and the new arrangement appears to be a routine operational restructuring of service provider relationships. Item 7.01 references an operational update press release announcing ETH holdings and staking metrics, which is promotional rather than disclosing a discrete material event. The contract restructuring is material to investors assessing operational efficiency but lacks the specificity of debt issuance, M&A, or other defined event types.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-08
Item 7.01
HCW Biologics announced entry into an Exclusive Distribution Agreement with Akron Biotech for commercialization of HCW11-006 as a reagent for CAR-T cell manufacturing. This is a material strategic partnership and commercial milestone for a clinical-stage biopharmaceutical company, involving pre-payment commitments and distribution through an established network. While not a traditional M&A transaction, it represents a significant operational and commercial development that would affect a reasonable investor's assessment of the company's commercialization strategy and revenue prospects.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-08
EX-99.1
The exhibit discloses a completed US$4.0 million private placement of common equity at US$1.00 per share (4,000,000 ordinary shares), representing approximately 160% above the closing price on August 19, 2026. This is a material unregistered equity issuance that increases share count and dilution to existing shareholders. The company explicitly frames this as part of a "capital discipline plan" designed to "limit potential dilution and securities overhang," acknowledging the dilutive nature of the transaction.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-08
EX-99.1
The press release announces entry into a strategic partnership agreement with SANVO Fine Chemicals Group Limited, appointing SANVO as the sole supplier and exclusive manufacturer for mass production of BocaPCM-TES Panels in China. This is a material operational and strategic business event that affects the Company's manufacturing strategy, capital expenditure plans, and market expansion timeline, but does not constitute a discrete M&A transaction, debt issuance, or other specifically-named event type. The partnership eliminates capital investments in new production lines and allows the Company to focus on R&D and global expansion.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-08
EX-99.1
This press release announces SMX's unveiling of a four-layer Digital Material Passport Platform (DMPP) for plastics, representing a significant product launch and strategic milestone. The disclosure describes the company's new integrated platform connecting physical plastic marking, digital passports, market trading infrastructure, and circularity credits. While this is a material operational and strategic development for the company's business, it does not fit neatly into the specific event categories (it is not M&A, earnings, executive changes, debt issuance, or other defined types). The announcement of a major new product platform and the opening of a global client experience with free trials constitutes a material operational event that would affect a reasonable investor's assessment of the company's strategic direction and commercial prospects.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-08
Timothy A. Peterman was appointed as Acting CFO of Laser Photonics Corporation on September 8, 2026, replacing Ralph Venegas who resumed his prior position as VP of Finance and Reporting. This is a material executive appointment disclosed under Item 5.02, as the CFO is a named executive officer whose appointment affects investor assessment of the company's financial leadership and governance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-08
EX-99.1
Draganfly announced its selection as a Qualified Supplier under Canada's Defence Drone Initiative Marketplace across all five capability streams, effective August 28, 2026. This is a material operational and strategic milestone that establishes a pathway for significant government contract opportunities with the Canadian Armed Forces and Coast Guard within a $180 billion defence procurement program. The qualification across all five streams positions the company to compete for substantial future defence contracts, making this a material business development event that would affect a reasonable investor's assessment of the company's growth prospects and market access.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-08
EX-99.1
The exhibit is a shareholder letter from CEO Heng Hai Lim disclosing NYSE American delisting proceedings initiated in June 2026 following an SEC trading suspension in February 2026. The Panel affirmed the delisting determination on August 20, 2026, and the Company has appealed to the Committee for Review. This is a material delisting risk disclosure under Item 3.01 equivalent, as the Company's securities have been delisted from NYSE American and are now trading OTC, with the outcome of the appeal uncertain.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-08
The filing discloses entry into multiple material debt agreements: a $400,000 senior secured loan with Hollywood Horizons (July 16, 2026) and a $666,666 senior secured loan with Abri Capital (August 12, 2026), plus amendments to existing debt obligations including conversion of a $840,000 Narrow Road promissory note into equity. While the filing also involves dilutive equity issuances (500,000 shares to each lender as commitment fees, plus 3,500,000 conversion shares), the primary disclosed action under Item 1.01 centers on entry into and amendment of direct financial obligations—new debt creation and restructuring of existing debt—making debt_issuance the most salient classification.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-08
EX-99.1
InterCure announced that it has regained compliance with Nasdaq's minimum bid price requirement after receiving a delisting notice on September 1, 2026. The company's shares had traded below $1.00 per share for 30 consecutive business days, triggering non-compliance in February 2026. Although the company ultimately regained compliance by September 8, 2026, the disclosure documents the delisting risk event and its resolution, which is material to investors assessing the registrant's continued listing status and market viability.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-08
Wenlong Tong, President of CIMG Inc., submitted a letter of resignation effective September 2, 2026, for personal reasons with no disagreement with the Company. This is a clear executive departure of a named officer (President), which is material to investors as it affects the registrant's leadership structure and operational continuity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-08
Item 1.01
Hepion Pharmaceuticals issued a $500,000 secured convertible note to Gravitas Capital LP on September 3, 2026, bearing 8% interest and maturing September 3, 2027, convertible into common stock at $0.04 per share and secured by all company assets.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-08
Item 1.01
StimCell Energetics entered into an Advisory Services Agreement with Stonegate Capital Markets on August 24, 2026, to identify and introduce prospective investors and strategic counterparties for potential transactions involving the Company's assets, debt, or equity securities. The engagement is a strategic advisory arrangement for capital-raising and M&A support on a best-efforts, non-exclusive basis with success-based compensation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-09-08
Item 1.01
GoPro issued a $20,000,000 convertible debenture to Yorkville on September 8, 2026, as the third closing under a previously disclosed securities purchase agreement. The instrument carries a specified maturity date of August 26, 2027, interest rate triggers, and conversion features into equity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-08
Item 3.02
GoPro issued conversion shares to Yorkville under an unregistered private placement pursuant to Section 4(a)(2) of the Securities Act, with the investor representing accredited investor status and investment intent.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-08
Item 8.01
X4 Pharmaceuticals announced a positive outcome from an FDA Type C Meeting regarding the 4WARD Phase 3 clinical trial for mavorixafor in chronic neutropenia. The FDA agreed to reduce the trial's sample size from 176 to 126 participants while maintaining statistical power for co-primary endpoints, and approved the proposed safety database for a potential supplemental new drug application. This is a material regulatory milestone affecting the clinical development pathway and timeline (enrollment expected by end-2026, topline data in H1 2028) for a key product candidate, making it a significant operational/strategic event for the company's pipeline, though it does not fit neatly into the specific event categories (not a restatement, impairment, covenant breach, or other defined type).
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-09-08
Item 7.01
Kosmos Energy is announcing a partial redemption of $25 million in aggregate principal amount of its 7.750% senior notes due 2027, with redemption expected on September 18, 2026. This is a debt management action—reducing outstanding debt obligations—that does not fit the specific categories of debt_issuance (creation of new obligations) or covenant_breach (violation of existing terms). The redemption is material to investors as it affects the company's capital structure and liquidity, but the disclosure is primarily informational rather than signaling financial distress or a major restructuring event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-08
Item 3.02
Wheeler Real Estate Investment Trust issued an aggregate of 841,628 shares of common stock in unregistered exchanges with existing preferred stockholders on September 2-3, 2026. The issuance was conducted under Section 3(a)(9) of the Securities Act (exemption for exchanges with existing security holders) and resulted in no cash proceeds to the company. This represents a material dilutive equity issuance to existing investors, characteristic of a dilutive_issuance event, and would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-08
Item 8.01
Silver Bow Mining announced completion of the initial closing in its acquisition of the Jefferson County Metallurgical Complex from Montana Tunnels Mining, Inc., following U.S. Bankruptcy Court approval under Section 363 of the Bankruptcy Code on September 4, 2026. The company funded approximately $28.58 million into escrow to satisfy creditor obligations as part of the transaction. This represents a material acquisition of specified assets, with a final closing contemplated subject to shareholder and NYSE American approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-08
Item 1.01
John Marshall Bancorp and Eagle Financial Services entered into a definitive Agreement and Plan of Merger on September 7, 2026, whereby EFSI will merge into John Marshall in an all-stock transaction valued at approximately $253 million (2.0 shares of JMSB per EFSI share). The transaction creates a combined $4.4 billion entity with 23 banking offices, expected to close in Q1 2027, and includes executive leadership changes at the effective time.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-09-08
YPF announced commencement of cash tender offers to repurchase up to US$500 million of outstanding debt securities (6.950% Senior Notes due 2027 and 2.500%/9.000% Step-Up Notes due 2029), concurrently with a primary offering of new Class XLIV Negotiable Obligations. This constitutes a material debt refinancing activity involving both debt retirement and new debt issuance, which affects the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-09-08
The filing discloses the appointment of Martín de los Ríos Plaza as a Regular Director for Class D shares by the Supervisory Committee, replacing the resigned director Maximiliano D'Alessio. While the resignation is also mentioned, the principal disclosed action is the appointment of a new director to fill the vacancy. Board-level director appointments are material governance events affecting the composition of the registrant's leadership.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-08
Cosan has filed Form 25 with the SEC for voluntary delisting of its American Depositary Shares from the NYSE, effective September 18, 2026. The company will transition to Level I ADR trading on the OTC market. This is a material change in listing status that directly affects the registrant's U.S. capital market access and is a core delisting_risk disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-09-08
Item 8.01
News Corporation discloses ongoing execution of a $1 billion share repurchase program authorized July 15, 2025, with approximately $463.3 million already deployed as of September 4, 2026. The filing reports daily buy-back notifications to the ASX showing purchases of Class A and Class B common stock at varying prices (ranging from $22.20 to $31.58). Share repurchases constitute a return of capital to shareholders and are classified as dividend_distribution under the taxonomy, as they represent a capital allocation decision materially affecting shareholder value.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-09-08
EX-99.1
Brightstar announced a tender offer for €500 million of existing 2.375% Senior Secured Notes due 2028 and a concurrent benchmark offering of new euro-denominated senior secured notes due 2032. The company intends to use proceeds from the New Notes to repay the tendered debt and revolving credit facilities, extending its weighted average debt maturity. This is a material debt refinancing transaction involving creation of new direct financial obligations (the New Notes) and restructuring of existing debt.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-08
Harmony reports a fatal workplace incident at its Moab Khotsong mine on September 6, 2026, involving a seismicity-related loss of life. While the disclosure is primarily operational and safety-related rather than fitting a specific named category, it is material to investors as it reflects operational risk, potential regulatory consequences, and management's commitment to safety—factors that affect the registrant's ability to operate its mines safely and profitably. The incident triggers an investigation by the Department of Mineral and Petroleum Resources, adding regulatory dimension.
View raw filing on EDGAR →